Phase 2 N=54 Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066
Obesity
Primary: Number of Episodes of Diarrhea (Part A and Part B) — 1.67; 1.25; 0.38; 1.88 Number of stools — p=0.202
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=129 Phase II Combination Steroid and Anti-VEGF for Persistent DME
Diabetic Macular Edema
Primary: Mean Change in Visual Acuity Letter Score — 2.7; 3.0 Letter Score
N/A N=281 Maternal-Offspring Metabolics:Family Intervention Trial
Pregnancy · Weight Gain
Primary: Gestational Weight Gain (GWG) — 12; 10 kg — p=0.01
N/A N=339 Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
Phase 3 N=80 A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban
Bleeding
Primary: Efficacy: Percent Change From Baseline in Anti-fXa Activity at the Nadir (Parts I and II) — -18.39; -92.22; -44.75; -96.72 Percent change in anti-fXa activity — p=<0.0001
Phase 2 N=52 A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
Metastatic Prostate Cancer
Primary: To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI). — 2.48; 1.48; 8.76; 5.08 10^3…
Phase 3 N=14 Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
X-linked Hypophosphatemia
Primary: Percent Change From Baseline in OV/BV at Week 48 — -54.18 percentage change of unmineralized bone — p=< 0.0001
Phase 2 N=140 A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan)
Congestion, Nasal
Primary: Change From Baseline in Mean Total Score of the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ) for Each Domain (Sleep, Sleep Time, Symptoms on…
Phase 2 N=31 A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Myelodysplastic Syndromes
Primary: Response to Treatment - Hematologic Improvement or Complete Response — 21 Participants
N/A N=561 Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Psoriasis Vulgaris · Plaque Psoriasis
Primary: The Course of Disease and Relapse Management During Treatment With Daivobet® Gel Under Consideration of Patient's Individual Application Habits Under Daily Use…
N/A N=30 Wii-Fit For Balance And Gait In Elderly Veterans
Gait, Unsteady · Postural Balance
Primary: Berg Balance Scale — 48.5; 50.1 units on a scale
Phase 4 N=143 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
Non-Small Cell Lung Cancer · Carcinoma · Squamous Cell Carcinoma
Primary: Percentage of Participants With Either Peripheral Neuropathy ≥ Grade 2 or Myelosuppression Adverse Events (AEs) ≥ Grade 3 Based on Local Laboratory Values — 76.5; 77.1…
N/A N=59 ClearWay Rx Readmission Registry
Acute Myocardial Infarction
Primary: 30 Day Readmissions — 7; 3; 59 participants
Phase 2 N=123 A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
Alzheimer's Disease
Primary: Change From Baseline (Day 0) in Cerebral Spinal Fluid (CSF) Amyloid Beta Peptide (Abeta) 42 and Abeta40 at Week 24 — -6.3; 33.6; -77.4; -327.7 Nanograms per Liter…
N/A N=44 Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals
Healthy Volunteers
Primary: HS-Omega-3 Index at Baseline and End of Study — 4.18; 4.32; 5.72; 4.50 HS-Omega-3 Index